Epigral Limited (BOM:543332)
India · Delayed Price · Currency is INR 1,829.95
-124.00 (-6.35%)
At close: Aug 4, 2025
Sage Therapeutics Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 3,577 | 1,959 | 3,533 | 2,528 | 1,008 | Upgrade |
Depreciation & Amortization | 1,326 | 1,236 | 1,090 | 859.06 | 735.45 | Upgrade |
Loss (Gain) From Sale of Assets | -50.4 | 0.5 | 0.05 | 0.72 | -0.03 | Upgrade |
Loss (Gain) From Sale of Investments | -18.7 | - | - | - | - | Upgrade |
Other Operating Activities | 1,239 | 1,166 | 1,231 | 1,145 | 604.82 | Upgrade |
Change in Accounts Receivable | -539 | -121.3 | 904.18 | -1,375 | -424.01 | Upgrade |
Change in Inventory | -1,250 | -511.6 | -576.89 | -1,002 | -55.57 | Upgrade |
Change in Accounts Payable | 30.8 | 553.3 | 224.07 | 147.69 | 259.68 | Upgrade |
Change in Other Net Operating Assets | 91.4 | -304.4 | -143.67 | 534.87 | 163.43 | Upgrade |
Operating Cash Flow | 4,406 | 3,976 | 6,262 | 2,838 | 2,292 | Upgrade |
Operating Cash Flow Growth | 10.79% | -36.50% | 120.62% | 23.82% | 39.22% | Upgrade |
Capital Expenditures | -1,947 | -3,984 | -4,165 | -4,563 | -1,968 | Upgrade |
Sale of Property, Plant & Equipment | 83.4 | - | - | - | 0.46 | Upgrade |
Investment in Securities | -754.7 | -27.4 | -205.65 | 13.79 | -0.6 | Upgrade |
Other Investing Activities | 2.6 | 0.8 | -2 | 2.94 | 0.81 | Upgrade |
Investing Cash Flow | -2,616 | -4,011 | -4,372 | -4,546 | -1,967 | Upgrade |
Short-Term Debt Issued | - | 1,292 | 115.66 | 51.08 | 553.15 | Upgrade |
Long-Term Debt Issued | 1,370 | 2,130 | 747.5 | 3,593 | 407 | Upgrade |
Total Debt Issued | 1,370 | 3,422 | 863.16 | 3,644 | 960.15 | Upgrade |
Short-Term Debt Repaid | -1,716 | - | - | - | - | Upgrade |
Long-Term Debt Repaid | -2,509 | -1,977 | -1,405 | -1,212 | -881.92 | Upgrade |
Total Debt Repaid | -4,225 | -1,977 | -1,405 | -1,212 | -881.92 | Upgrade |
Net Debt Issued (Repaid) | -2,855 | 1,445 | -541.91 | 2,433 | 78.24 | Upgrade |
Issuance of Common Stock | 3,331 | - | - | - | - | Upgrade |
Preferred Dividends Paid | -103.2 | -147.5 | -138.55 | - | - | Upgrade |
Common Dividends Paid | -315.4 | -103.7 | -103.7 | - | - | Upgrade |
Dividends Paid | -418.6 | -251.2 | -242.24 | - | - | Upgrade |
Other Financing Activities | -742.7 | -720.2 | -604.52 | -480.39 | -397.23 | Upgrade |
Financing Cash Flow | -1,635 | -76 | -1,998 | 1,952 | -319 | Upgrade |
Net Cash Flow | 154.6 | -110.6 | -108.45 | 244.05 | 5.83 | Upgrade |
Free Cash Flow | 2,459 | -8 | 2,097 | -1,725 | 324.17 | Upgrade |
Free Cash Flow Margin | 9.64% | -0.04% | 9.58% | -11.12% | 3.91% | Upgrade |
Free Cash Flow Per Share | 58.21 | -0.19 | 50.47 | -41.51 | 5.55 | Upgrade |
Cash Interest Paid | 659.4 | 720.2 | 604.52 | 480.39 | 397.23 | Upgrade |
Cash Income Tax Paid | 1,105 | 505.3 | 1,075 | 604.49 | 286.2 | Upgrade |
Levered Free Cash Flow | 790.56 | -1,416 | 358.67 | -2,560 | -364.91 | Upgrade |
Unlevered Free Cash Flow | 1,079 | -957.28 | 772.26 | -2,264 | -171.78 | Upgrade |
Change in Net Working Capital | 1,914 | 448.04 | -206.55 | 1,209 | 112.88 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.